Initiating adalimumab in conjunction with clindamycin and rifampicin improves clinical response in Hidradenitis Suppurativa
Published: 7 September 2023| Version 1 | DOI: 10.17632/t4kwnyb7pk.1
Contributor:
Pim AartsDescription
Supplemental data to: 'Initiating adalimumab in conjunction with clindamycin and rifampicin improves clinical response in Hidradenitis Suppurativa.'
Files
Institutions
Erasmus MC
Categories
Hidradenitis Suppurativa